Over the past 12 months, 8 insiders at Immuneering Corp filed 12 open-market SEC Form 4 transactions on IMRX: 12 purchases worth $398K and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Jun 23, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 26 | Benjamin J. ZeskindPRESIDENT AND CEO | BUY | 2.4K | $4.56 | $11K |
| Jan 16, 26 | Harold Eugene BrakewoodChief Business Officer | BUY | 5.3K | $4.76 | $25K |
| Jan 15, 26 | Brett Matthew HallCHIEF SCIENTIFIC OFFICER | BUY | 2.3K | $4.57 | $11K |
| Jan 15, 26 | Thomas J. SchallDirector | BUY | 21.6K | $4.67 | $101K |
| Jan 13, 26 | Leah R NeufeldCHIEF PEOPLE OFFICER | BUY | 2.6K | $4.15 | $11K |
| Jan 12, 26 | Peter FeinbergDirector | BUY | 20.0K | $4.35 | $87K |
| Oct 3, 25 | Peter FeinbergDirector | BUY | 7.5K | $6.67 | $50K |
| Oct 1, 25 | Michael BookmanCHIEF LEGAL OFFICER, SECRETARY | BUY | 1.0K | $6.83 | $7K |
| Oct 1, 25 | Mallory MoralesChief Accounting Officer | BUY | 300 | $6.39 | $2K |
| Oct 1, 25 | Leah R NeufeldCHIEF PEOPLE OFFICER | BUY | 800 | $6.38 | $5K |
| Sep 30, 25 | Peter FeinbergDirector | BUY | 7.5K | $7.03 | $53K |
| Sep 29, 25 | Peter FeinbergDirector | BUY | 5.0K | $7.18 | $36K |
| Jul 2, 25 | Diana HausmanDirector | BUY | 3.0K | $3.62 | $11K |
| Jul 2, 25 | Leah R NeufeldCHIEF PEOPLE OFFICER | BUY | 700 | $3.57 | $2K |
| Jul 2, 25 | Benjamin J. ZeskindPRESIDENT AND CEO | BUY | 7.0K | $3.53 | $25K |
| Jul 1, 25 | Benjamin J. ZeskindPRESIDENT AND CEO | BUY | 3.0K | $3.38 | $10K |
| Jun 27, 25 | Thomas J. SchallDirector | BUY | 9.5K | $3.66 | $35K |
| Jun 23, 25 | Brett Matthew HallCHIEF SCIENTIFIC OFFICER | BUY | 6.0K | $2.43 | $15K |
| Jun 20, 25 | Harold Eugene BrakewoodChief Business Officer | BUY | 1.9K | $2.53 | $5K |
| Jun 20, 25 | Brett Matthew HallCHIEF SCIENTIFIC OFFICER | BUY | 7.4K | $2.70 | $20K |
| Jun 18, 25 | Peter FeinbergDirector | BUY | 25.0K | $2.53 | $63K |
| Jun 18, 25 | Benjamin J. ZeskindPRESIDENT AND CEO | BUY | 21.0K | $2.39 | $50K |
| Jun 17, 25 | Thomas J. SchallDirector | BUY | 40.5K | $2.21 | $89K |
| Apr 1, 24 | Cormorant Private Healthcare Fund III LpTenPercentOwner | SELL | 398.6K | $3.07 | $1.2M |
| Mar 22, 24 | Harold Eugene BrakewoodChief Business Officer | BUY | 3.9K | $2.57 | $10K |
| Mar 22, 24 | Peter FeinbergDirector | BUY | 25.0K | $2.55 | $64K |
| Mar 22, 24 | Thomas J. SchallDirector | BUY | 2.9K | $2.55 | $7K |
| Mar 22, 24 | Mallory MoralesChief Accounting Officer | BUY | 393 | $2.55 | $1K |
| Mar 21, 24 | Mallory MoralesChief Accounting Officer | BUY | 1.1K | $2.72 | $3K |
| Mar 20, 24 | Brett Matthew HallCHIEF SCIENTIFIC OFFICER | BUY | 7.0K | $2.86 | $20K |
| Mar 20, 24 | Leah R NeufeldCHIEF PEOPLE OFFICER | BUY | 3.8K | $2.88 | $11K |
| Mar 19, 24 | Benjamin J. ZeskindPRESIDENT AND CEO | BUY | 20.0K | $2.77 | $55K |
| Mar 19, 24 | Peter FeinbergDirector | BUY | 25.0K | $2.56 | $64K |
| Mar 18, 24 | Ann E BermanDirector | BUY | 58.0K | $2.13 | $123K |
| Mar 18, 24 | Peter FeinbergDirector | BUY | 45.0K | $3.05 | $104K |
| Mar 15, 24 | Cormorant Global Healthcare Master Fund, LpTenPercentOwner | SELL | 400.0K | $2.14 | $856K |
| Mar 14, 24 | Cormorant Global Healthcare Master Fund, LpTenPercentOwner | SELL | 345.3K | $5.97 | $1.1M |
| May 25, 22 | Brett Matthew HallCHIEF SCIENTIFIC OFFICER | BUY | 2.6K | $3.92 | $10K |
| May 17, 22 | Michael BookmanGENERAL COUNSEL AND SECRETARY | BUY | 1.0K | $4.88 | $5K |
| May 16, 22 | Laurie KeatingDirector | BUY | 7.0K | $5.00 | $35K |
| May 12, 22 | Biren AminCFO, TREASURER | BUY | 1.0K | $4.42 | $4K |
| Mar 23, 22 | Brett Matthew HallCHIEF SCIENTIFIC OFFICER | BUY | 1.1K | $7.91 | $8K |
| Mar 23, 22 | Benjamin J. ZeskindPRESIDENT AND CEO | BUY | 3.0K | $8.02 | $24K |
| Mar 22, 22 | Scott BarrettCHIEF MEDICAL OFFICER | BUY | 900 | $7.49 | $7K |
| Mar 15, 22 | Ann E BermanDirector | BUY | 6.0K | $6.40 | $38K |
| Mar 15, 22 | Peter FeinbergDirector | BUY | 6.7K | $6.75 | $45K |
| Sep 20, 21 | Peter FeinbergDirector | BUY | 4.8K | $24.45 | $116K |
| Sep 13, 21 | Peter FeinbergDirector | BUY | 5.8K | $21.51 | $124K |
| Sep 13, 21 | Benjamin J. ZeskindPRESIDENT AND CEO | BUY | 2.1K | $22.87 | $48K |
| Aug 3, 21 | Biren AminCFO, Treasurer | BUY | 4.2K | $15.00 | $63K |
Over the past 12 months, insiders at Immuneering Corp filed 12 open-market purchases worth $398K and 0 sales worth $0 on IMRX, which makes them net buyers over the period. The most recent Form 4 was filed on Jun 23, 26.
The largest recent open-market IMRX insider purchase in our data was $124K by Peter Feinberg, Director, filed on Sep 13, 21.
8 different insiders at Immuneering Corp filed open-market SEC Form 4 transactions on IMRX over the last 12 months.
InsiderTape plots every IMRX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Immuneering Corp insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →